EVH · Evolent Health, Inc Class A
Evolent Health Inc (EVH)
What's happening
- EVH is down 0.72% today, trading at $4.84. — Live quote
- Volume today (111,279) is well below its 3-month average of 2,818,010. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (after market close), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.02 actual vs. $-0.02 estimated (+183.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-10-01 (18 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 |
|---|---|---|---|---|---|
| Market cap | $614.4M | $253.0M | $446.5M | $734.2M | $509.4M |
| P/E | -1.22 | -0.51 | -0.84 | -5.73 | -3.90 |
| Price/Sales | 0.29 | 0.13 | 0.24 | 0.36 | 0.23 |
| Price/Book | 1.60 | 0.64 | 1.08 | 0.87 | 0.57 |
| EV/Revenue | 0.70 | 0.57 | 0.67 | 0.82 | 0.54 |
| ROE | -131.77% | -125.26% | -128.74% | -15.22% | -14.56% |
| ROA | -25.61% | -26.43% | -28.14% | -5.22% | -5.30% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 46.9% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-08-28; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -24.1%. Finnhub fundamentals ↗
- Trailing 52-week price return is -37.2%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on EVH
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $652.5M | $496.2M | $468.7M | $479.5M | $444.3M | $483.6M | $646.5M | $621.4M |
| Operating income | -$9.6M | -$10.6M | — | $886.0K | -$1.2M | -$1.6M | — | -$16.3M |
| Net income | -$28.4M | -$26.6M | -$429.1M | -$20.9M | -$19.9M | -$64.6M | -$22.8M | -$23.1M |
| EPS (diluted) | $-0.25 | $-0.24 | $-3.84 | $-0.24 | $-0.44 | $-0.63 | $-0.27 | $-0.27 |
| EPS (basic) | $-0.25 | $-0.24 | $-3.84 | $-0.24 | $-0.44 | $-0.63 | $-0.27 | $-0.27 |
| Operating margin | -$1 | -$2 | — | $0 | -$0 | -$0 | — | -$3 |
| Net margin | -$4 | -$5 | -$92 | -$4 | -$4 | -$13 | -$4 | -$4 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.97B | $1.88B | $1.90B | $2.45B | $2.46B | $2.65B | $2.54B | $2.50B |
| Total liabilities | $1.59B | $1.48B | $1.48B | $1.61B | $1.34B | $1.52B | $1.35B | $1.28B |
| Stockholders' equity | $383.2M | $396.4M | $415.2M | $842.2M | $896.0M | $935.5M | $1.00B | $1.04B |
| Total current assets | $610.5M | $502.0M | $506.4M | $570.1M | $562.3M | $727.9M | $607.1M | $544.0M |
| Total current liabilities | $492.8M | $381.2M | $385.3M | $429.9M | $557.5M | $739.1M | $715.5M | $523.7M |
| Cash & equivalents | $115.7M | $142.0M | $151.9M | $116.7M | $151.0M | $246.5M | $104.2M | $96.6M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $449.1M | $314.2M | $309.9M | $386.6M | $358.8M | $430.5M | $414.7M | $407.9M |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $81.9M | $81.2M | $80.8M | $80.1M | $77.3M | $74.4M | $73.2M | $73.9M |
| Goodwill | $694.4M | $694.4M | $694.5M | $1.08B | $1.14B | $1.14B | $1.14B | $1.14B |
| Intangible assets | $554.4M | $569.7M | $584.9M | $623.7M | $651.2M | $667.9M | $680.2M | $696.8M |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Accounts payable | $38.8M | $63.0M | $59.8M | $72.2M | $69.5M | $57.8M | $96.0M | $50.1M |
| Accrued liabilities | $43.9M | $45.1M | $65.8M | $60.9M | $63.9M | $99.5M | $66.4M | $120.5M |
| Deferred revenue (current) | $1.2M | $1.4M | $1.2M | $1.9M | $2.3M | $5.0M | $2.5M | $2.6M |
| Short-term debt | — | — | $0 | $5.1M | $172.1M | $171.8M | $171.5M | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | $966.5M | $973.5M | $970.5M | $1.05B | $648.5M | $647.5M | $490.5M | $599.7M |
| Other non-current liabilities | $8.1M | $8.1M | $8.0M | $3.8M | $3.8M | $3.3M | $3.0M | $3.2M |
| Common stock & paid-in capital | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M |
| Retained earnings | -$1.37B | -$1.34B | -$1.32B | -$886.2M | -$865.3M | -$845.4M | -$780.8M | -$758.0M |
| Accumulated other comprehensive income (loss) | -$3.6M | -$3.6M | -$2.6M | -$2.4M | -$1.7M | -$1.7M | -$1.8M | -$1.4M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.3M | -$984.0K | $48.8M | $15.8M | -$30.3M | $4.6M | -$26.2M | $18.7M |
| Investing cash flow | -$6.7M | -$6.4M | $82.2M | -$8.8M | -$60.5M | -$13.1M | -$19.9M | -$19.7M |
| Financing cash flow | -$11.0M | -$4.0M | -$93.0M | -$41.8M | -$8.9M | $107.9M | $96.9M | -$9.0M |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Depreciation & amortization | $21.6M | $21.6M | $45.0M | $23.6M | $23.1M | $24.1M | $29.3M | $29.7M |
| Share-based compensation | $15.2M | $10.6M | $2.4M | $14.7M | $11.6M | $11.1M | -$6.1M | $14.4M |
| Deferred income taxes | — | — | -$15.0M | — | — | — | -$18.8M | — |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in accounts payable | -$23.2M | $5.4M | -$14.9M | $3.3M | $14.9M | $3.3M | $3.0M | $16.6M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Other investing activities | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | $0 | $40.0M | — | — | $0 | $0 |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | $166.8M | $0 | $62.5M | $0 | $0 |
| Tax withholding on stock comp | $7.0K | $1.8M | $58.0K | $547.0K | $28.0K | $4.6M | $309.0K | $692.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $1.88B | $2.55B | $1.96B | $1.35B | $908.0M |
| Operating income | -$410.1M | -$40.5M | -$71.2M | $3.6M | -$42.4M |
| Net income | -$534.5M | -$61.6M | -$113.0M | -$19.2M | -$37.6M |
| EPS (diluted) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 |
| EPS (basic) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 |
| Operating margin | -$22 | -$2 | -$4 | $0 | -$5 |
| Net margin | -$28 | -$2 | -$6 | -$1 | -$4 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.90B | $2.54B | $2.68B | $1.82B | $1.42B |
| Total liabilities | $1.48B | $1.35B | $1.43B | $957.9M | $725.8M |
| Stockholders' equity | $415.2M | $1.00B | $1.07B | $859.4M | $693.6M |
| Total current assets | $506.4M | $607.1M | $683.7M | $478.1M | $524.0M |
| Total current liabilities | $385.3M | $715.5M | $674.2M | $433.4M | $445.5M |
| Cash & equivalents | $151.9M | $104.2M | $192.8M | $188.2M | $266.3M |
| Marketable securities (current) | — | — | — | — | — |
| Accounts receivable | $309.9M | $414.7M | $446.7M | $254.7M | $130.6M |
| Marketable securities (non-current) | — | — | — | — | — |
| Property, plant & equipment | $80.8M | $73.2M | $78.2M | $87.9M | $81.4M |
| Goodwill | $694.5M | $1.14B | $1.12B | $722.8M | $426.3M |
| Intangible assets | $584.9M | $680.2M | $752.0M | $442.8M | $279.8M |
| Accounts payable | $59.8M | $96.0M | $48.2M | $57.2M | $96.1M |
| Accrued liabilities | $65.8M | $66.4M | $149.8M | $111.2M | $107.2M |
| Deferred revenue (current) | $1.2M | $2.5M | $6.0M | $5.8M | $11.9M |
| Short-term debt | $0 | $171.5M | $0 | — | — |
| Long-term debt | $970.5M | $490.5M | $597.0M | $413.0M | $215.7M |
| Other non-current liabilities | $8.0M | $3.0M | $3.6M | $4.7M | $5.5M |
| Common stock & paid-in capital | $1.2M | $1.2M | $1.2M | $1.0M | $908.0K |
| Retained earnings | -$1.32B | -$780.8M | -$719.2M | -$606.2M | -$626.8M |
| Accumulated other comprehensive income (loss) | -$2.6M | -$1.8M | -$1.3M | -$1.2M | -$362.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $38.8M | $18.8M | $142.6M | -$11.6M | $38.7M |
| Investing cash flow | -$233.0K | -$62.9M | -$415.5M | -$259.1M | -$15.8M |
| Financing cash flow | -$35.9M | -$565.0K | $281.3M | $131.5M | -$29.5M |
| Capital expenditures | — | — | — | — | — |
| Depreciation & amortization | $115.9M | $118.4M | $123.4M | $67.2M | $60.0M |
| Share-based compensation | $39.7M | $39.7M | $40.5M | $34.0M | $16.7M |
| Deferred income taxes | -$15.0M | -$18.8M | -$54.5M | $2.4M | -$10.4M |
| Change in accounts receivable | — | — | — | — | — |
| Change in accounts payable | $6.6M | $4.2M | -$6.7M | $13.2M | $7.2M |
| Purchases of investments | — | — | — | — | — |
| Other investing activities | — | — | — | $0 | $0 |
| Share repurchases | $40.0M | $0 | $0 | — | — |
| Debt issued | — | — | $647.5M | $219.7M | $0 |
| Debt repaid | — | $0 | $464.2M | $0 | $98.4M |
| Tax withholding on stock comp | $5.2M | $15.7M | $15.3M | $18.3M | $3.9M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding EVH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 01:26 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-28 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-04 | View on SEC.gov → |
Recent news
Headlines about EVH (Evolent Health, Inc Class A). Links open the publisher — we don’t host full articles.
-
SUNS,BNL,FG,BCDA,NTHI,ZOMDF,BATRA,ATLO,OPAL,MRP,NEOG,PEB,SAIC,INNV,NEWT,VG,MTDR,LUCK,GROV,EVH,IRIX,BUSE,RNXT,BLNE | Stock Prices | Quote Comparison - Yahoo Finance
Yahoo! Finance Canada · 2026-10-21 -
SUNS,BNL,BCDA,FG,NTHI,ZOMDF,BATRA,ATLO,OPAL,NEOG,PEB,SAIC,INNV,NEWT,MTDR,VG,LUCK,GROV,EVH,AWRE,IRIX,BUSE,RNXT,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,BNL,BCDA,FG,ZOMDF,NTHI,BATRA,ATLO,OPAL,MRP,NEOG,PEB,SAIC,INNV,NEWT,MTDR,VG,LUCK,GROV,EVH,BUSE,IRIX,BLNE,RNXT | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,BCDA,FG,BNL,NTHI,ZOMDF,BATRA,ATLO,OPAL,MRP,NEOG,PEB,SAIC,INNV,NEWT,VG,MTDR,LUCK,GROV,EVH,IRIX,BUSE,RNXT,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,FG,BNL,NTHI,ZOMDF,BATRA,ATLO,OPAL,NEOG,PEB,SAIC,INNV,NEWT,MTDR,VG,LUCK,GROV,EVH,AWRE,BUSE,IRIX,BLNE,RNXT | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,BNL,FG,BCDA,NTHI,ZOMDF,BATRA,ATLO,OPAL,MRP,NEOG,PEB,SAIC,INNV,NEWT,VG,MTDR,LUCK,GROV,EVH,IRIX,BUSE,BLNE,RNXT | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
Evolent Health(EVH) Stock Options Chain | Quotes & News
Moomoo · 2026-10-21 -
SUNS,BCDA,FG,BNL,NTHI,ZOMDF,BATRA,ATLO,OPAL,MRP,NEOG,PEB,SAIC,INNV,NEWT,VG,MTDR,LUCK,GROV,EVH,BUSE,IRIX,BLNE,RNXT | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-20
No headlines in this category right now — try “All”.